HomeXLO • NASDAQ
add
Xilio Therapeutics Inc
Previous close
$1.10
Day range
$1.01 - $1.15
Year range
$0.49 - $3.40
Market cap
36.53M USD
Avg Volume
2.33M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
AMZN
1.29%
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 18.13M | -21.74% |
Net income | -17.66M | 21.41% |
Net profit margin | — | — |
Earnings per share | -0.64 | 21.95% |
EBITDA | -17.68M | 22.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 44.70M | -62.87% |
Total assets | 60.93M | -56.22% |
Total liabilities | 24.10M | -28.10% |
Total equity | 36.83M | — |
Shares outstanding | 34.47M | — |
Price to book | 0.83 | — |
Return on assets | -65.32% | — |
Return on capital | -77.92% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -17.66M | 21.41% |
Cash from operations | -13.43M | 26.32% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | -1.63M | -7,680.95% |
Net change in cash | -15.06M | 19.69% |
Free cash flow | -7.07M | 37.03% |
About
Founded
2016
Headquarters
Website
Employees
73